Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 15, Issue 5-6, 2014, Pages 351-356

  Feneberg, Emily ^a   Steinacker, Petra ^a   Lehnert, Stefan ^a   Schneider, Anja ^b   Walther, Paul ^a   Thal, Dietmar R ^a   Linsenmeier, Miriam ^a   Ludolph, Albert C ^a   Otto, Markus ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Biomarker; Cerebrospinal fluid; Exosomes; Frontotemporal lobar degeneration; TDP 43

Indexed keywords

TAR DNA BINDING PROTEIN; UREA; DNA BINDING PROTEIN; FLOTILLINS; MEMBRANE PROTEIN; PROTEIN TDP-43;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; BRAIN LEVEL; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXOSOME; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; BLOOD; CEREBROSPINAL FLUID; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; NEURODEGENERATIVE DISEASES; ULTRASTRUCTURE;

AGED; DNA-BINDING PROTEINS; EXOSOMES; FEMALE; HUMANS; LYMPHOCYTES; MALE; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MOLECULAR WEIGHT; NEURODEGENERATIVE DISEASES;

EID: 84906330760     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.905606     Document Type: Article

References (36)

1. Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci. 2008; 13: 867-78
2. Cohen T J, Lee VM, Trojanowski JQ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med. 2011; 17: 659-67
3. Fiesel F C, Kahle P J. TDP-43 and FUS/TLS: Cellular functions and implications for neurodegeneration. FEBS J. 2011; 278: 3550-68
4. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314: 130-3
5. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351: 602-11
6. Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology. 2010; 30: 170-81
7. Steinacker P, Hendrich C, Sperfeld A D, Jesse S, von Arnim CA, Lehnert S, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008; 65: 1481-7
8. Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008; 116: 141-6
9. Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 2009; 118: 647-58
10. Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009; 117: 55-62
11. Verstraete E, Kuiperij HB, van Blitterswijk MM, Veldink JH, Schelhaas HJ, Van Den Berg LH, et al. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012; 13: 446-51
12. Felgenhauer K. Protein size and cerebrospinal fluid composition. Klin Wochenschr. 1974; 52: 1158-64
13. Reiber H. Flow rate of cerebrospinal fluid (CSF): A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. JNeurol Sci. 1994; 122: 189-203
14. Lehnert S, Jesse S, Rist W, Steinacker P, Soininen H, Herukka SK, et al. iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia. Exp Neurol. 2012; 234: 499-505
15. Pradat P F, Bruneteau G. Clinical characteristics of amyotrophic lateral sclerosis subsets. Rev Neurol (Paris). 2006; 162 Spec No 2: 4S29-33
16. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-54
17. Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: Epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010; 24: 375-98
18. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134: 2456-77
19. Gorno-Tempini M L, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76: 1006-14
20. Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. JPathol. 2007; 211: 582-90
21. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9: 581-93
22. Keller S, Sanderson M P, Stoeck A, Altevogt P. Exosomes: From biogenesis and secretion to biological function. Immunol Lett. 2006; 107: 102-8
23. Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J. 2008; 37: 323-32
24. Heijnen HF, Schiel A E, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999; 94: 3791-9
25. Nieuwland R, Berckmans RJ, McGregor S, Boing A N, Romijn FP, Westendorp RG, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000; 95: 930-5
26. Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, Lehnert S, et al. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Proteomics. 2008; 8: 4357-66
27. Lehnert S, Jesse S, Rist W, Steinacker P, Soininen H, Herukka SK, et al. iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia. Exp Neurol. 2012; 234: 499-505
28. Wiltfang J, Smirnov A, Schnierstein B, Kelemen G, Matthies U, Klafki HW, et al. Improved electrophoretic separation and immunoblotting of beta-Amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis. 1997; 18: 527-32
29. Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. JCell Biol. 1999; 147: 599-610
30. Raposo G, Nijman H W, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. Blymphocytes secrete antigenpresenting vesicles. JExp Med. 1996; 183: 1161-72
31. de Marco G, Lupino E, Calvo A, Moglia C, Buccinna B, Grifoni S, et al. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol. 2011; 121: 611-22
32. Alquezar C, Esteras N, Bartolome F, Merino JJ, Alzualde A, Munain AL, et al. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G-A PGRN mutation associated with FTLD-TDP dementia. Neurobiol Aging. 2012; 33: 429.e7-20
33. Schneider A, Simons M. Exosomes: Vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res. 2013; 352: 33-47
34. Bellingham SA, Guo BB, Coleman BM, Hill A F. Exosomes: Vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol. 2012; 3: 124
35. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). JBiol Chem. 1987; 262: 9412-20
36. Street J M, Barran P E, Mackay C L, Weidt S, Balmforth C, Walsh TS, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. JTransl Med. 2012; 10: 5